◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksA › ASTH

Astrana Health Inc (ASTH) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL CARE FACILITIES · DATA UPDATED 2026-09-13

Astrana Health Inc (ASTH) operates in the MEDICAL CARE FACILITIES industry and is headquartered in Alhambra, United States with about 3,000 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, ASTH reported $3.2B in revenue and $22M in net income.

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.

Interactive charts & full statements → Open the ASTH valuation workbench →

ASTH Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$3.8B$3.2B$2.0B$1.4B$1.1B$774M$370M$561M$520M$358M$57M$44M$33M$10M$8M$5M$4M$2M$1M$0M
Gross Profit$355M$296M$271M$215M$199M$178M$22M$93M$139M$64M$9M$10M$11M$1M$1M$1M$1M$1M$0M
Gross Margin %9.2%9.3%13.3%15.5%17.4%23.0%5.9%16.6%26.8%17.9%15.1%22.0%33.1%13.4%18.8%19.1%14.9%25.7%1.1%
Operating Income (EBIT)$100M$79M$89M$85M$104M$98M$6M$32M$92M$38M($11M)($7M)($1M)($4M)($2M)$0M$0M$0M($1M)$0M$0M
Operating Margin %2.6%2.5%4.4%6.1%9.1%12.7%1.6%5.8%17.7%10.5%-18.4%-14.9%-2.1%-37.3%-26.7%-8.1%0.1%-4.2%-79.0%-36.6%
Net Income$40M$22M$43M$61M$45M$69M($24M)$14M$11M$26M($9M)($9M)($2M)($5M)($9M)($1M)$0M$0M($1M)$0M$0M
Net Margin %1.0%0.7%2.1%4.4%4.0%8.9%-6.4%2.5%2.1%7.2%-15.6%-21.2%-5.5%-47.9%-114.5%-14.1%-4.0%-8.0%-84.3%-36.6%
EBITDA$174M$135M$142M$124M$112M$101M$30M$49M$102M$69M($10M)($7M)$0M($4M)($2M)$0M$0M$0M($1M)$0M$0M
Earnings Per Share (EPS)$0.82$0.46$0.89$1.29$0.99$1.52$-0.63$0.39$0.29$0.90$-1.49$-1.79$-0.37$-1.07$-2.56$-0.25$-0.06$-0.07$-0.37$-0.12$-1.57
Shares Outstanding (M)50M49M48M47M46M45M37M36M38M29M6M5M5M5M3M3M3M3M2M0M0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ASTH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$973M$965M$951M$956M$655M$620M$665M$479M
Gross Profit$104M$90M$79M$82M$78M$71M$63M$73M
Gross Margin %10.7%9.3%8.3%8.5%11.9%11.5%9.5%15.3%
Operating Income (EBIT)$34M$29M$18M$19M$20M$21M$1M$28M
Operating Margin %3.5%3.0%1.9%2.0%3.1%3.3%0.1%5.9%
Net Income$20M$14M$6M$0M$9M$7M($7M)$16M
Net Margin %2.0%1.5%0.6%0.0%1.4%1.1%-1.0%3.4%
EBITDA$43M$51M$41M$39M$31M$24M$14M$43M
Earnings Per Share (EPS)$0.40$0.29$0.12$0.01$0.19$0.14$-0.15$0.33
Shares Outstanding (M)50M49M50M49M49M49M48M48M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ASTH Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$108M$115M$52M$68M$82M$70M$46M$14M$26M$53M($8M)($2M)$0M($1M)$0M$0M$0M$0M($1M)$0M$0M
Capital Expenditures (CapEx)$14M$10M$8M$29M$23M$19M$1M$1M$1M$2M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M
Free Cash Flow (FCF)$94M$104M$44M$40M$59M$51M$45M$13M$25M$51M($8M)($2M)$0M($2M)$0M$0M$0M$0M($1M)$0M$0M
FCF Margin %2.4%3.3%2.2%2.9%5.2%6.6%12.2%2.2%4.8%14.2%-14.7%-4.8%-1.0%-14.3%0.2%-7.7%-6.8%-13.9%-60.1%-13.1%
Dividends Paid$2M$8M$4M$62M$14M$31M$51M$62M$18M$10M$1M$1M$1M$0M$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ASTH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$33M$68M($3M)$10M$91M$17M($11M)$34M
Capital Expenditures (CapEx)$4M$4M$3M$3M$1M$3M$3M$2M
Free Cash Flow (FCF)$29M$64M($6M)$7M$89M$14M($13M)$32M
FCF Margin %3.0%6.6%-0.6%0.8%13.7%2.2%-2.0%6.6%
Dividends Paid$0M$0M$2M$0M$1M$5M$2M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ASTH Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$2.3B$2.2B$1.4B$933M$966M$867M$817M$729M$513M$491M$21M$20M$9M$9M$3M$1M$1M$1M$0M$0M$0M
Cash & Cash Equivalents$401M$429M$288M$294M$288M$233M$193M$103M$107M$120M$9M$9M$7M$7M$1M$0M$0M$1M$0M$0M
Total Liabilities$1.7B$1.7B$841M$523M$408M$357M$372M$368M$106M$154M$20M$11M$11M$11M$4M$2M$1M$1M$1M$0M$0M
Total Debt (Short + Long-Term)$945M$1.0B$441M$284M$208M$187M$244M$245M$13M$6M$10M$2M$8M$2M$3M$1M$0M$0M$0M$0M$0M
Total Shareholders' Equity$830M$779M$713M$614M$543M$448M$331M$192M$181M$160M$0M$6M($2M)($2M)$0M$0M$0M$0M$0M$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ASTH viewer.

Other Companies in MEDICAL CARE FACILITIES

← ASTGAll “A” companiesASTI →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.